Cargando…
Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? The single pill of amlodipine/atorvastatin
In order to prevent cardiovascular events, it is essential to effectively manage overall risk of cardiovascular disease. However, despite guideline recommendations to this effect, current management of the major, modifiable cardiovascular risk factors such as hypertension and dyslipidemia is disconn...
Autor principal: | Richard Hobbs, FD |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291315/ https://www.ncbi.nlm.nih.gov/pubmed/18078022 |
Ejemplares similares
-
Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen
por: Patel, Bimal V, et al.
Publicado: (2008) -
Patient adherence and preference considerations in managing cardiovascular risk: focus on single pill and amlodipine/atorvastatin fixed combination
por: Aslam, Farhan, et al.
Publicado: (2009) -
Amlodipine + atorvastatin single pill is the most effective choice for primary prevention
por: Aalbers, J
Publicado: (2010) -
Is Time an Important Problem in Management of Hypertension and Hypercholesterolemia by Using an Amlodipine-Atorvastatin Single Pill Combination?
por: Zeng, Rui, et al.
Publicado: (2016) -
EFFICACY AND SAFETY OF A SINGLE-PILL COMBINATION OF ATORVASTATIN/AMLODIPINE IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
por: Naydenov Naydenov, Stefan, et al.
Publicado: (2018)